Strides completes US$1.75 billion sale of Agila Specialties to Mylan
Date closed: 12/4/2013
Value: US$1.75 billion
On December 4, 2013, Strides Arcolab Ltd completed the sale of its Agila Specialties Pharma Corporation business to Mylan Inc. for a total consideration of up to US$1.75 billion.
Strides Arcolab, headquartered in Bangalore, India, is a global pharmaceutical company.
BLG acted as Canadian counsel to Strides Arcolab Limited with a team led by
Pascal de Guise that included
Yaniv Saragosti,
Ryan Tomicic,
Daniel Urbas and
Brian Schneiderman.
